Cytos Biotechnology
Latest round
- Series C
Last raised
- Jan 2002
Total raised
- $65M
Investors
- 15
About Cytos Biotechnology
Cytos Biotechnology Ltd.Founded in 1995 and headquartered in Schlieren, Switzerland, Cytos Biotechnology Ltd. specializes in the research and development of biopharmaceuticals. The company has undergone changes in its business strategies over the years, but specific pivots are not documented. Cytos Biotechnology has successfully executed 9 deals in its operational history, with its most recent deal occurring on October 29, 2002, when the company was listed on the Swiss Exchange.Cytos Biotechnology focuses on the development of biopharmaceutical products designed to treat autoimmune diseases and allergies. The company utilizes proprietary technologies to create innovative therapies intended to improve patient outcomes in these areas.Cytos Biotechnology generates its revenue through the commercialization of its biopharmaceutical products, targeting healthcare providers and institutions. The revenue is derived from product sales that have received necessary regulatory approvals for use in treating specific medical conditions.Cytos Biotechnology is focused on advancing its product pipeline to introduce new therapies targeting autoimmune diseases and allergies. Plans for market expansion are not detailed, nor is specific release date information for upcoming products available.
Who invested in Cytos Biotechnology
15 investors across 3 rounds
See all investors in Cytos Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cytos Biotechnology
Who invested in Cytos Biotechnology?
Cytos Biotechnology has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cytos Biotechnology raised?
Cytos Biotechnology has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Cytos Biotechnology last raise money?
Cytos Biotechnology's most recent round on record is a Series C, in Jan 2002.
What does Cytos Biotechnology do?
Cytos Biotechnology is a biotechnology company.
Where is Cytos Biotechnology headquartered?
Cytos Biotechnology is headquartered in Schlieren, Switzerland.
Which VCs invest in companies like Cytos Biotechnology?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Cytos Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Cytos Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.